Seres Therapeutics Financials
| MCRB Stock | USD 0.71 0.02 2.74% |
Seres |
Please note, the presentation of Seres Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Seres Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Seres Therapeutics' management manipulating its earnings.
Seres Therapeutics Stock Summary
Seres Therapeutics competes with Iovance Biotherapeutics, Veracyte, and Fate Therapeutics. Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Seres Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 333 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US81750R1023 |
| CUSIP | 81750R102 |
| Location | Massachusetts; U.S.A |
| Business Address | 101 Cambridgepark Drive, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.serestherapeutics.com |
| Phone | 617 945 9626 |
| Currency | USD - US Dollar |
Seres Therapeutics Key Financial Ratios
| Return On Equity | -15.56 | ||||
| Return On Asset | -0.3 | ||||
| Target Price | 3.82 | ||||
| Number Of Employees | 103 | ||||
| Beta | 2.17 |
Seres Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Seres Therapeutics's current stock value. Our valuation model uses many indicators to compare Seres Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seres Therapeutics competition to find correlations between indicators driving Seres Therapeutics's intrinsic value. More Info.Seres Therapeutics is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Seres Therapeutics' earnings, one of the primary drivers of an investment's value.Seres Therapeutics Systematic Risk
Seres Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Seres Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Seres Therapeutics correlated with the market. If Beta is less than 0 Seres Therapeutics generally moves in the opposite direction as compared to the market. If Seres Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Seres Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Seres Therapeutics is generally in the same direction as the market. If Beta > 1 Seres Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
About Seres Therapeutics Financials
What exactly are Seres Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Seres Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Seres Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Seres Therapeutics investors may use each financial statement separately, they are all related. The changes in Seres Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Seres Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Seres Therapeutics Thematic Clasifications
Seres Therapeutics is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Pharmaceutical Products | View |
Seres Therapeutics March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Seres Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Seres Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Seres Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Seres Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Seres Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 35.32 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 7.81 |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |